1. Home
  2. CVRX vs DIN Comparison

CVRX vs DIN Comparison

Compare CVRX & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
    SELLHOLDBUYas of 19 hours ago
  • DIN
    SELLHOLDBUYas of 19 hours ago
  • Stock Information
  • Founded
  • CVRX 2000
  • DIN 1958
  • Country
  • CVRX United States
  • DIN United States
  • Employees
  • CVRX N/A
  • DIN N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DIN Restaurants
  • Sector
  • CVRX Health Care
  • DIN Consumer Discretionary
  • Exchange
  • CVRX Nasdaq
  • DIN Nasdaq
  • Market Cap
  • CVRX 419.8M
  • DIN 468.5M
  • IPO Year
  • CVRX 2021
  • DIN 1991
  • Fundamental
  • Price
  • CVRX $12.98
  • DIN $23.81
  • Analyst Decision
  • CVRX Strong Buy
  • DIN Hold
  • Analyst Count
  • CVRX 7
  • DIN 8
  • Target Price
  • CVRX $17.83
  • DIN $29.50
  • AVG Volume (30 Days)
  • CVRX 171.5K
  • DIN 638.7K
  • Earning Date
  • CVRX 04-29-2025
  • DIN 03-05-2025
  • Dividend Yield
  • CVRX N/A
  • DIN 8.57%
  • EPS Growth
  • CVRX N/A
  • DIN N/A
  • EPS
  • CVRX N/A
  • DIN 4.22
  • Revenue
  • CVRX $51,292,000.00
  • DIN $812,306,000.00
  • Revenue This Year
  • CVRX $27.21
  • DIN $1.02
  • Revenue Next Year
  • CVRX $25.87
  • DIN $1.15
  • P/E Ratio
  • CVRX N/A
  • DIN $5.64
  • Revenue Growth
  • CVRX 30.53
  • DIN N/A
  • 52 Week Low
  • CVRX $6.40
  • DIN $22.36
  • 52 Week High
  • CVRX $19.24
  • DIN $46.26
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 54.12
  • DIN 42.27
  • Support Level
  • CVRX $11.95
  • DIN $22.82
  • Resistance Level
  • CVRX $12.94
  • DIN $25.10
  • Average True Range (ATR)
  • CVRX 0.59
  • DIN 0.98
  • MACD
  • CVRX 0.18
  • DIN -0.02
  • Stochastic Oscillator
  • CVRX 83.18
  • DIN 35.61

Stock Price Comparison Chart: CVRX vs DIN

CVRX
DIN
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090100CVRX VS DIN

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations, and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use